Author: healthadmin
Drugs designed to mimic GLP-1 and promote weight loss may also help limit further heart damage after a heart attack. A new study led by researchers at the University of Bristol and University of London (UCL) has found that these drugs may reduce the risk of serious complications that occur in up to half of heart attack patients. The survey results are nature communicationssuggest that GLP-1 reduction drugs may provide a new strategy to improve recovery after heart attack. Previous studies have already shown that GLP-1 weight loss drugs may reduce the chance of serious heart disease. Remarkably, these benefits…
Why Logerie Works Who works: The Rogerie is a Kelowna-based recycling studio owned by Brayden and Angela Rogers. What works: Rogerie uses more than a dozen 3D printers to turn plastic waste from across Canada into products such as soap dishes, planters and drink tumblers. Braden Rogers estimates that the company will have diverted 6,000 kilograms of plastic waste from landfills in 2025. What works for bioregions: A small portion of the plastic produced in Canada and the United States is recycled each year. This model shows a new way to turn waste into usable materials. Brayden Rodgers loves second…
Electrical engineers at Duke University have developed the fastest pyroelectric photodetector ever demonstrated. This pyroelectric photodetector is a device that detects light by sensing a minute amount of heat generated when light is absorbed. The ultra-thin sensor can capture light across the entire electromagnetic spectrum. It operates at room temperature, requires no external power supply, and can be directly integrated into on-chip systems. This technology could ultimately enable a new generation of multispectral cameras with applications in areas such as skin cancer detection, food safety surveillance, and large-scale agriculture. The findings were reported in the journal Advanced Functional Materials. Why…
An experimental treatment for children with severe and difficult-to-treat epilepsy appears to be safe and highly effective in reducing seizures, according to results from an international clinical trial led by University College London and Great Ormond Street Hospital. The findings suggest that this treatment could significantly improve the health and daily life of affected children. This study New England Medical Journalfound that children with Dravet syndrome had seizures reduced by up to 91 percent while regularly receiving an investigational drug called zorebnersen. Researchers also reported early evidence that the treatment may help alleviate some of the disorder’s effects on thinking…
Researchers from several international organizations have revealed new details about how the malaria parasite grows and spreads. Their research has identified specialized proteins required by the parasite to survive and move between hosts, making it a promising target for future antimalarial drugs. The discovery focuses on a molecule known as Aurora-associated kinase 1 (ARK1). In a study published in nature communicationsCollaborators at the University of Nottingham, the National Institute of Immunology (NII) in India, the University of Groningen in the Netherlands, the Francis Crick Institute, and others have discovered that ARK1 acts like a cellular traffic controller during abnormal parasite…
Wearable sensors may help identify multiple sclerosis (MS) patients who are more likely to experience worsening disability and loss of brain volume, according to research published on March 4, 2026. Neurology®Medical Journal of the American Academy of Neurology. The study found that people who had changes in their activity patterns were more likely to have worsening disorders or a reduction in brain volume than people whose patterns did not change much or at all. This study does not prove that changes in activity lead to progression of MS. Just show the relevance. Wearable sensors measure how much light, moderate, or…
How people with compromised immune systems respond to vaccines is an important area of immunological research. A new study led by the University of York found that machine learning models were not only able to accurately identify differences between healthy controls and people infected with HIV, but also found outliers in both groups that offered an interesting glimpse into the complex nature of the immune system and what future personalized medicine might look like, taking into account variables such as age, comorbidities and genetics. This study represents an important step forward in the potential of personalized vaccination intervention strategies.…
A groundbreaking Phase 1/2a clinical trial co-led by Linda Lo, MD, of the Ann and Robert H. Lurie Children’s Hospital of Chicago, shows that the first gene-modulating treatment for epilepsy is safe and well-tolerated in patients with Dravet syndrome who are unresponsive to antiepileptic drugs. The result is New England Medical Journalincluding a significant reduction in seizures and improvement in other symptoms of Dravet syndrome, such as speech, motor, and behavior problems. Researchers are also reporting sustained treatment effects in an ongoing open-label extension study. Our results are very promising, especially since there is currently no approved treatment that…
New international research published in lancet e-clinical medicine mapped global blood transfusion practices for life-threatening abdominal injuries, highlighting significant differences in care around the world and opportunities for health systems to learn from each other. The study was led by the University of Cambridge as part of the GOAL-Trauma study and analyzed data from 1,768 patients treated at 187 hospitals in 51 countries. This is the first multicenter study to report on blood transfusion strategies for patients undergoing emergency abdominal surgery after trauma (trauma laparotomy). Uncontrolled bleeding is the leading cause of death after abdominal trauma, making optimal blood transfusion…
A year after stopping taking weight-loss drugs such as Ozempic or Wegoby, people regain 60% of the weight they lost on average, but beyond that the weight plateaus and some people manage to keep 25% of the weight they lost on treatment, say researchers at the University of Cambridge. However, it is not clear whether the weight gain consists of both fat and muscle, or whether it consists primarily of fat. Previous research suggests that lean body mass, including muscle, may account for up to 40% of the total body weight lost during treatment. More than 1 billion people worldwide…